Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Guardado en:

Detalles Bibliográficos
Autor principal:	Juan Tamargo
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/f7f531e9dbad468e8cec0e108f45481d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f7f531e9dbad468e8cec0e108f45481d
record_format	dspace
spelling	oai:doaj.org-article:f7f531e9dbad468e8cec0e108f45481d2021-12-04T16:02:16ZCorrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments10.15420/ecr.2019.14.3.CG11758-37641758-3756https://doaj.org/article/f7f531e9dbad468e8cec0e108f45481d2019-12-01T00:00:00Zhttps://www.ecrjournal.com/articles/Sodium-Glucose-Cotransporter-2-Inhibitors-Heart-Failurehttps://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Juan TamargoRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 14, Iss 3, Pp 201-201 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Juan Tamargo Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
format	article
author	Juan Tamargo
author_facet	Juan Tamargo
author_sort	Juan Tamargo
title	Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
title_short	Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
title_full	Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
title_fullStr	Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
title_full_unstemmed	Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
title_sort	corrigendum to: sodium–glucose cotransporter 2 inhibitors in heart failure: potential mechanisms of action, adverse effects and future developments
publisher	Radcliffe Medical Media
publishDate	2019
url	https://doaj.org/article/f7f531e9dbad468e8cec0e108f45481d
work_keys_str_mv	AT juantamargo corrigendumtosodiumglucosecotransporter2inhibitorsinheartfailurepotentialmechanismsofactionadverseeffectsandfuturedevelopments
_version_	1718372770732048384

Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Ejemplares similares